1. Home
  2. CTNM vs LVRO Comparison

CTNM vs LVRO Comparison

Compare CTNM & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • LVRO
  • Stock Information
  • Founded
  • CTNM 2009
  • LVRO 2017
  • Country
  • CTNM United States
  • LVRO Brazil
  • Employees
  • CTNM N/A
  • LVRO N/A
  • Industry
  • CTNM
  • LVRO Blank Checks
  • Sector
  • CTNM
  • LVRO Finance
  • Exchange
  • CTNM Nasdaq
  • LVRO Nasdaq
  • Market Cap
  • CTNM 248.7M
  • LVRO 205.1M
  • IPO Year
  • CTNM 2024
  • LVRO N/A
  • Fundamental
  • Price
  • CTNM $12.16
  • LVRO N/A
  • Analyst Decision
  • CTNM Strong Buy
  • LVRO Sell
  • Analyst Count
  • CTNM 5
  • LVRO 3
  • Target Price
  • CTNM $22.20
  • LVRO $1.88
  • AVG Volume (30 Days)
  • CTNM 194.4K
  • LVRO 202.8K
  • Earning Date
  • CTNM 11-05-2025
  • LVRO 10-30-2025
  • Dividend Yield
  • CTNM N/A
  • LVRO N/A
  • EPS Growth
  • CTNM N/A
  • LVRO N/A
  • EPS
  • CTNM N/A
  • LVRO N/A
  • Revenue
  • CTNM N/A
  • LVRO $1,667,345,189.00
  • Revenue This Year
  • CTNM N/A
  • LVRO N/A
  • Revenue Next Year
  • CTNM N/A
  • LVRO $11.45
  • P/E Ratio
  • CTNM N/A
  • LVRO N/A
  • Revenue Growth
  • CTNM N/A
  • LVRO N/A
  • 52 Week Low
  • CTNM $3.35
  • LVRO $1.25
  • 52 Week High
  • CTNM $20.24
  • LVRO $5.60
  • Technical
  • Relative Strength Index (RSI)
  • CTNM 56.27
  • LVRO 44.88
  • Support Level
  • CTNM $10.65
  • LVRO $1.46
  • Resistance Level
  • CTNM $12.14
  • LVRO $1.94
  • Average True Range (ATR)
  • CTNM 0.92
  • LVRO 0.16
  • MACD
  • CTNM -0.21
  • LVRO -0.00
  • Stochastic Oscillator
  • CTNM 34.98
  • LVRO 33.25

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

Share on Social Networks: